Myopia Drops

Atropine+ combines low-dose atropine (0.01%, 0.025% and 0.05%) with a soothing lubricant and 50% less BAK preservative (0.005%).

Studies show that a low dose of atropine, typically administered as eye drops in the evening, has the potential to significantly slow the progression of myopia in children – helping prevent severe nearsightedness.1 2

To make caring for children's vision simpler, OSRX offers three low-dose Atropine+ drops. We compound 0.01%, 0.025% and 0.05% concentrations, allowing you to customize myopia treatment by patient. Our OMNI Atropine+ eye drops ship directly to your patients or practice (your choice) at no added cost.

How to Prescribe:  New prescribers must complete an OSRX new prescriber registration form. Once completed, a member of our staff will contact you to discuss pricing, prescribing process and shipping details. 

Questions? Contact your rep here.

Atropine Sulfate 0.01%
Sterile Ophthalmic Solution 

Potential Contraindications

3.5 mL

Atropine Sulfate 0.025%
Sterile Ophthalmic Solution 

Potential Contraindications

3.5 mL

Atropine Sulfate 0.05%
Sterile Ophthalmic Solution

Potential Contraindications

3.5 mL

Dr. Stephanie Tsang Testimonial



What is Atropine+?
Atropine+ is a customized medication that combines low-dose atropine with a soothing lubricant and 50% less BAK (now 0.005%) – all for the same affordable price as our current Atropine medications.

Will the pricing change?
No. Your patients' current pricing will remain the same. 

Will the bottle or label look different to my patient?
The Atropine+ bottle cap colors will remain the same, however you’ll notice a subtle design change to the label.

Atropine+ Bottle Comparison

Will the prescribing process change?  
No. You may submit patient-specific prescriptions for Atropine+ using your eRx system or the HIPAA-compliant OSRX Prescriber Portal. 

Will I need to submit new prescriptions for patients with an active prescription and refills for Atropine?  
No. No action is required for patients to continue receiving their prescriptions. Should you wish to opt out of prescribing Atropine+, please contact us. 

Do I need to complete a NEW prescriber registration form to prescribe Atropine+? 

  • Are you a current prescriber? If so, no. Please note that we believe Atropine+ is substitutable because it combines low-dose atropine with a soothing lubricant and 50% less BAK. Should you wish to opt out of prescribing this new medication, please contact us.  
  • Are you a NEW prescriber? If so, yes. Please fill out an OSRX new prescriber registration form here and a representative will contact you shortly.

1Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2, Chia, Audrey et al., Ophthalmology, Volume 123, Issue 2, 391 – 399

2Yam JC, Jiang Y, Tang SM, et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology. 2019;126(1):113-124. doi:10.1016/j.ophtha.2018.05.029

Professional Disclosure:  Dr. Tsang has a financial interest in Ocular Science (an affiliate of OSRX).

OSRX operates in compliance with Section 503A regarding compounded drugs as defined in the FD&C Act.

*Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality. 503A compounding pharmacies are not required to comply with cGMP requirements but can be inspected by FDA. References available upon request.

Click here to view potential contraindications.